Bayer Group cut its fiscal year 2023 outlook, mainly due to a significant further decline in sales of glyphosate-based products.
For full-year 2023, Bayer now anticipates sales to be between 48.5 billion euros and 49.5 billion euros on a currency-adjusted basis, i.e. based on the average monthly exchange rates in 2022. Previously, it expected sales of 51 billion euros to 52 billion euros.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com